Rohtesh S. Mehta

7.1k total citations · 1 hit paper
135 papers, 2.1k citations indexed

About

Rohtesh S. Mehta is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Rohtesh S. Mehta has authored 135 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 31 papers in Oncology and 25 papers in Immunology. Recurrent topics in Rohtesh S. Mehta's work include Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (35 papers) and Immune Cell Function and Interaction (22 papers). Rohtesh S. Mehta is often cited by papers focused on Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (35 papers) and Immune Cell Function and Interaction (22 papers). Rohtesh S. Mehta collaborates with scholars based in United States, South Africa and United Kingdom. Rohtesh S. Mehta's co-authors include Katayoun Rezvani, Elizabeth J. Shpall, Amin M. Alousi, Roy E. Smith, Marcin Chwistek, Richard E. Champlin, Partow Kebriaei, Michael Levy, Uday Popat and James M. Reuben and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rohtesh S. Mehta

123 papers receiving 2.1k citations

Hit Papers

Liposomal Amphotericin B for the Treatment of Systemic Fu... 1985 2026 1998 2012 1985 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
    1985 329 citations Rohtesh S. Mehta et al. profile →

Peers

Rohtesh S. Mehta
Christian Koenecke Germany
Wei Han China
Parinda A. Mehta United States
Tsila Zuckerman Israel
Jean‐Hugues Dalle France
Jaime Sanz Spain
Koichiro Yuji Japan
Jeffery J. Auletta United States
Feng‐Rong Wang China
Leona Holmberg United States
Christian Koenecke Germany
Rohtesh S. Mehta
Citations per year, relative to Rohtesh S. Mehta Rohtesh S. Mehta (= 1×) peers Christian Koenecke

Countries citing papers authored by Rohtesh S. Mehta

Since Specialization
Citations

This map shows the geographic impact of Rohtesh S. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohtesh S. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohtesh S. Mehta more than expected).

Fields of papers citing papers by Rohtesh S. Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohtesh S. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohtesh S. Mehta. The network helps show where Rohtesh S. Mehta may publish in the future.

Co-authorship network of co-authors of Rohtesh S. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Rohtesh S. Mehta. A scholar is included among the top collaborators of Rohtesh S. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohtesh S. Mehta. Rohtesh S. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mehta, Rohtesh S., Rodney Sparapani, Christopher G. Kanakry, et al.. (2025). Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide vs Conventional Prophylaxis. JAMA Oncology. 12(1). 28–28. 2 indexed citations
3.
Mehta, Rohtesh S., Hannah Choe, Jennifer N. Saultz, et al.. (2025). Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Hematology. 100(6). 987–997.
4.
Mehta, Rohtesh S., Yosra Aljawai, Partow Kebriaei, et al.. (2025). The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 31(11). 920.e1–920.e14. 1 indexed citations
5.
Aljawai, Yosra, Jeremy Ramdial, Gabriela Rondón, et al.. (2025). Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis. Blood Advances. 9(15). 4023–4036. 2 indexed citations
6.
Mehta, Rohtesh S., Stephanie J. Lee, Ted Gooley, et al.. (2025). Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies. Blood Advances. 9(11). 2691–2694.
7.
Mehta, Rohtesh S., et al.. (2025). Steroid Refractory Acute GVHD: The Hope for a Better Tomorrow. American Journal of Hematology. 100(S3). 14–29. 3 indexed citations
8.
Mehta, Rohtesh S., Yosra Aljawai, Taha Al‐Juhaishi, et al.. (2025). Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis. Transplantation and Cellular Therapy. 31(9). 672.e1–672.e9. 1 indexed citations
9.
Mehta, Rohtesh S.. (2024). SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection. Clinical Lymphoma Myeloma & Leukemia. 24(12). 821–826. 2 indexed citations
10.
Carpenter, Paul A., Theodore A. Gooley, Catherine J. Lee, et al.. (2024). Decreasing chronic graft-versus-host disease rates in all populations. Blood Advances. 8(22). 5829–5837. 6 indexed citations
11.
Mehta, Rohtesh S., Effie W. Petersdorf, Tao Wang, Stephen R. Spellman, & Stephanie J. Lee. (2024). Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT. Blood Advances. 8(20). 5438–5449. 2 indexed citations
12.
Mehta, Rohtesh S., Effie W. Petersdorf, Tao Wang, & Stephanie J. Lee. (2024). Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplantation and Cellular Therapy. 30(9). 909.e1–909.e11. 6 indexed citations
13.
Alousi, Amin M., Jin S. Im, LaQuisa Hill, et al.. (2024). Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease. Bone Marrow Transplantation. 59(11). 1594–1600. 1 indexed citations
14.
Mehta, Rohtesh S., Haris Ali, Voravit Ratanatharathorn, et al.. (2023). A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement. Bone Marrow Transplantation. 58(9). 991–999. 5 indexed citations
15.
Short, Nicholas J., Farhad Ravandi, Graciela M. Nogueras‐González, et al.. (2023). Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation. Blood Advances. 7(14). 3573–3581. 13 indexed citations
16.
Mehta, Rohtesh S., Amin M. Alousi, Christopher G. Kanakry, et al.. (2023). Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. Blood Advances. 7(8). 1594–1603. 13 indexed citations
17.
18.
Lachowiez, Curtis A., Sarah A. Bannon, Sanam Loghavi, et al.. (2020). Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations. American Journal of Hematology. 95(11). E313–E315. 3 indexed citations
19.
Oran, Betül, Guillermo Garcia‐Manero, Rima M. Saliba, et al.. (2020). Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors. Cancer. 126(10). 2193–2205. 31 indexed citations
20.
Rezvani, Katayoun, Betül Oran, Rohtesh S. Mehta, et al.. (2018). Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 25(3). 505–514. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Koenecke Breakdown of academic impact, for papers by Wei Han Breakdown of academic impact, for papers by Parinda A. Mehta Breakdown of academic impact, for papers by Tsila Zuckerman Breakdown of academic impact, for papers by Jean‐Hugues Dalle Breakdown of academic impact, for papers by Jaime Sanz Breakdown of academic impact, for papers by Koichiro Yuji Breakdown of academic impact, for papers by Jeffery J. Auletta Breakdown of academic impact, for papers by Feng‐Rong Wang Breakdown of academic impact, for papers by Leona Holmberg
Rankless by CCL
2026